{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:46:11Z","timestamp":1775843171012,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Elabela is a bioactive peptide and a part of Apelinergic system. Elabela has an important role in the early embryonic stages. Elabela's beneficial effects in cardiovascular system were shown in some animal models or in vitro studies. Lately, some investigational studies in humans are started to be seen in literature. Our aims were to investigate serum Elabela levels in the first day of ST segment elevation myocardial infarction (STEMI), to compare with healthy controls, and to see if there is a correlation between other cardiac biomarkers in humans.<\/jats:p>\n            <jats:p>The study was planned as cross-sectional. The patients group had 124 STEMI subjects. They were grouped as inferior (n\u200a=\u200a59) and anterior myocardial infarction (n\u200a=\u200a65) groups, and compared with the healthy control population (n\u200a=\u200a77). Routine blood tests and serum Elabela levels were measured. Transthoracic echocardiography performed to all subjects.<\/jats:p>\n            <jats:p>Frequency of diabetes mellitus, hypertension, smoking, and hyperlipidemia in both STEMI groups were significantly higher than control subjects. Glucose, high density lipoprotein (HDL) cholesterol, triglyceride, high sensitive C reactive protein (Hs-CRP), troponin I, N-terminal brain natriuretic peptide (NT-ProBNP), and Elabela levels were significantly higher in both STEMI groups. Other laboratory parameters were similar. Group 2 and 3 had significantly lower left ventricular ejection fraction (LVEF) than group 1. Group 3 had also significantly lower LVEF than group 2. There was a positive but moderate correlation between Elabela, troponin I, and NT-ProBNP. Elabela was negatively correlated with LVEF. This correlation was also moderate.<\/jats:p>\n            <jats:p>We showed increased Elabela levels in STEMI patients in this study. Also, we observed a moderate positive correlation between troponin I, NT-ProBNP, and Elabela.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000017645","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T19:22:49Z","timestamp":1571858569000},"page":"e17645","source":"Crossref","is-referenced-by-count":25,"title":["Increased Elabela levels in the acute ST segment elevation myocardial infarction patients"],"prefix":"10.1097","volume":"98","author":[{"given":"Yurdaer","family":"D\u00f6nmez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arma\u011fan","family":"Acele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,10]]},"reference":[{"key":"R1-20240516","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"R2-20240516","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-015-0521-6","article-title":"Characterization of apela, a novel endogenous ligand of apelin receptor, in the adult heart","volume":"111","author":"Perj\u00e9s","year":"2016","journal-title":"Basic Res Cardiol"},{"key":"R3-20240516","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00395-007-0671-2","article-title":"Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury","volume":"102","author":"Simpkin","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"R4-20240516","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2006.09.034","article-title":"Apelin increases contractility in failing cardiac muscle","volume":"553","author":"Dai","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"R5-20240516","doi-asserted-by":"crossref","first-page":"H2007","DOI":"10.1152\/ajpheart.00089.2009","article-title":"Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension","volume":"296","author":"Falc\u00e3o-Pires","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R6-20240516","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.devcel.2013.11.002","article-title":"ELABELA: a hormone essential for heart development signals via the apelin receptor","volume":"27","author":"Chng","year":"2013","journal-title":"Dev Cell"},{"key":"R7-20240516","doi-asserted-by":"crossref","first-page":"1248636","DOI":"10.1126\/science.1248636","article-title":"Toddler: an embryonic signal that promotes cell movement via Apelin receptors","volume":"343","author":"Pauli","year":"2014","journal-title":"Science"},{"key":"R8-20240516","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.peptides.2018.09.006","article-title":"Elabela, a newly discovered APJ ligand: similarities and differences with Apelin","volume":"109","author":"Zhang","year":"2018","journal-title":"Peptides"},{"key":"R9-20240516","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvx061","article-title":"ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage","volume":"113","author":"Sato","year":"2017","journal-title":"Cardiovasc Res"},{"key":"R10-20240516","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1021\/acs.jmedchem.5b01549","article-title":"Discovery and structure-activity relationship of a bioactive fragment of ELABELA that modulates vascular and cardiac functions","volume":"59","author":"Murza","year":"2016","journal-title":"J Med Chem"},{"key":"R11-20240516","doi-asserted-by":"crossref","first-page":"e000249","DOI":"10.1161\/JAHA.113.000249","article-title":"Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemiareperfusion injury: therapeutic potential of synthetic Apelin analogues","volume":"2","author":"Wang","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"R12-20240516","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1152\/ajpendo.00383.2018","article-title":"ELABELA, as a potential diagnostic biomarker of pre-eclampsia, regulates abnormally shallow placentation via APJ","volume":"316","author":"Zhou","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R13-20240516","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1159\/000492093","article-title":"Serum Elabela\/Toddler levels are associated with albuminuria in patients with type 2 diabetes","volume":"48","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R14-20240516","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1093\/abbs\/gmx098","article-title":"Elabela-APJ axis: a novel therapy target for cardiovascular diseases","volume":"49","author":"Li","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R15-20240516","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"R16-20240516","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and The Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"R17-20240516","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"R18-20240516","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-017-0482-9","article-title":"Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review","volume":"17","author":"Johansson","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"R19-20240516","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.3390\/s120404974","article-title":"Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease","volume":"12","author":"Watanabe","year":"2012","journal-title":"Sensors (Basel)"},{"key":"R20-20240516","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cphy.c170028","article-title":"Apelinergic system structure and function","volume":"8","author":"Shin","year":"2017","journal-title":"Compr Physiol"},{"key":"R21-20240516","doi-asserted-by":"crossref","first-page":"6472","DOI":"10.1002\/jcp.26492","article-title":"Biological functions of Elabela, a novel endogenous ligand of APJ receptor","volume":"233","author":"Xu","year":"2018","journal-title":"J Cell Physiol"},{"key":"R22-20240516","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10989-018-9707-8","article-title":"ELABELA (ELA) peptide exerts cardioprotection against myocardial infarction by targeting oxidative stress and the improvement of heart function","volume":"25","author":"Rakhshan","year":"2018","journal-title":"Int J Pept Res Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T22:06:14Z","timestamp":1715897174000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":22,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017645","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}